{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:09:15Z","timestamp":1792001355352,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81361128006"],"award-info":[{"award-number":["81361128006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008838","name":"Shanghai Municipal Commission of Economy and Informatization","doi-asserted-by":"publisher","award":["20184Y0256"],"award-info":[{"award-number":["20184Y0256"]}],"id":[{"id":"10.13039\/501100008838","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Biallelic variants in <jats:italic>HSD3B7<\/jats:italic> cause 3\u03b2-hydroxy-\u0394<jats:sup>5<\/jats:sup>-C<jats:sub>27<\/jats:sub>-steroid oxidoreductase (HSD3B7) deficiency, a life-threatening but treatable liver disease. The goal of this study was to obtain detailed information on the correlation between the genotype and phenotype of HSD3B7 deficiency and to report on responses to primary bile acid therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The medical records of a cohort of 39 unrelated patients with genetically and biochemically confirmed HSD3B7 deficiency were examined to determine whether there exist genotype-phenotype relationships in this bile acid synthesis disorder.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In all, 34 of the 44 variants identified in <jats:italic>HSD3B7<\/jats:italic> were novel. A total of 32 patients presented early with neonatal cholestasis, and 7 presented after 1-year of age with liver failure (n\u2009=\u20091), liver cirrhosis (n\u2009=\u20093), cholestasis (n\u2009=\u20091), renal cysts and abnormal liver biochemistries (n\u2009=\u20091), and coagulopathy from vitamin K1 deficiency and abnormal liver biochemistries (n\u2009=\u20091). Renal lesions, including renal cysts, renal stones, calcium deposition and renal enlargement were observed in 10 of 35 patients. Thirty-three patients were treated with oral chenodeoxycholic acid (CDCA) resulting in normalization of liver biochemistries in 24, while 2 showed a significant clinical improvement, and 7 underwent liver transplantation or died. Remarkably, renal lesions in 6 patients resolved after CDCA treatment, or liver transplantation. There were no significant correlations between genotype and clinical outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In what is the largest cohort of patients with HSD3B7 deficiency thus far studied, renal lesions were a notable clinical feature of HSD3B7 deficiency and these were resolved with suppression of atypical bile acids by oral CDCA administration.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-021-02041-7","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T19:35:43Z","timestamp":1633894543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Genetic spectrum and clinical characteristics of 3\u03b2-hydroxy-\u03945-C27-steroid oxidoreductase (HSD3B7) deficiency in China"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3208-9009","authenticated-orcid":false,"given":"Jing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth D. R.","family":"Setchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Heubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinbao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0823-586X","authenticated-orcid":false,"given":"Jian-She","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,9]]},"reference":[{"issue":"4","key":"2041_CR1","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1172\/JCI112915","volume":"79","author":"PT Clayton","year":"1987","unstructured":"Clayton PT, Leonard JV, Lawson AM, Setchell KD, Andersson S, Egestad B, et al. Familial giant cell hepatitis associated with synthesis of 3 beta, 7 alpha-dihydroxy-and 3 beta,7 alpha, 12 alpha-trihydroxy-5-cholenoic acids. J Clin Invest. 1987;79(4):1031\u20138.","journal-title":"J Clin Invest"},{"issue":"9","key":"2041_CR2","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1172\/JCI10902","volume":"106","author":"M Schwarz","year":"2000","unstructured":"Schwarz M, Wright AC, Davis DL, Nazer H, Bjorkhem I, Russell DW. The bile acid synthetic gene 3beta-hydroxy-Delta(5)-C(27)-steroid oxidoreductase is mutated in progressive intrahepatic cholestasis. J Clin Invest. 2000;106(9):1175\u201384.","journal-title":"J Clin Invest"},{"issue":"4","key":"2041_CR3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.cld.2018.06.006","volume":"22","author":"JE Heubi","year":"2018","unstructured":"Heubi JE, Setchell KDR, Bove KE. Inborn errors of bile acid metabolism. Clin Liver Dis. 2018;22(4):671\u201387.","journal-title":"Clin Liver Dis"},{"issue":"1","key":"2041_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/MPG.0b013e3181b47b34","volume":"50","author":"P Subramaniam","year":"2010","unstructured":"Subramaniam P, Clayton PT, Portmann BC, Mieli-Vergani G, Hadzic N. Variable clinical spectrum of the most common inborn error of bile acid metabolism\u20133beta-hydroxy-Delta 5-C27-steroid dehydrogenase deficiency. J Pediatr Gastroenterol Nutr. 2010;50(1):61\u20136.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"2041_CR5","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/MPG.0000000000001546","volume":"64","author":"J Jahnel","year":"2017","unstructured":"Jahnel J, Zohrer E, Fischler B, D\u2019Antiga L, Debray D, Dezsofi A, et al. Attempt to determine the prevalence of two inborn errors of primary bile acid synthesis: results of a European survey. J Pediatr Gastroenterol Nutr. 2017;64(6):864\u20138.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"2041_CR6","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/hep.24781","volume":"55","author":"V Molho-Pessach","year":"2012","unstructured":"Molho-Pessach V, Rios JJ, Xing C, Setchell KD, Cohen JC, Hobbs HH. Homozygosity mapping identifies a bile acid biosynthetic defect in an adult with cirrhosis of unknown etiology. Hepatology. 2012;55(4):1139\u201345.","journal-title":"Hepatology"},{"issue":"5","key":"2041_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/adc.80.5.463","volume":"80","author":"AK Akobeng","year":"1999","unstructured":"Akobeng AK, Clayton PT, Miller V, Super M, Thomas AG. An inborn error of bile acid synthesis (3beta-hydroxy-delta5-C27-steroid dehydrogenase deficiency) presenting as malabsorption leading to rickets. Arch Dis Child. 1999;80(5):463\u20135.","journal-title":"Arch Dis Child"},{"issue":"1","key":"2041_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13023-018-0920-5","volume":"13","author":"E Gonzales","year":"2018","unstructured":"Gonzales E, Matarazzo L, Franchi-Abella S, Dabadie A, Cohen J, Habes D, et al. Cholic acid for primary bile acid synthesis defects: a life-saving therapy allowing a favorable outcome in adulthood. Orphanet J Rare Dis. 2018;13(1):190.","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl 1","key":"2041_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/01.mpg.0000226386.79483.7b","volume":"43","author":"KD Setchell","year":"2006","unstructured":"Setchell KD, Heubi JE. Defects in bile acid biosynthesis\u2013diagnosis and treatment. J Pediatr Gastroenterol Nutr. 2006;43(Suppl 1):17\u201322.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"2041_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/BF01800342","volume":"15","author":"SP Horslen","year":"1992","unstructured":"Horslen SP, Lawson AM, Malone M, Clayton PT. 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency; effect of chenodeoxycholic acid therapy on liver histology. J Inherit Metab Dis. 1992;15(1):38\u201346.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"2041_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10024-002-1201-8","volume":"7","author":"KE Bove","year":"2004","unstructured":"Bove KE, Heubi JE, Balistreri WF, Setchell KD. Bile acid synthetic defects and liver disease: a comprehensive review. Pediatr Dev Pathol. 2004;7(4):315\u201334.","journal-title":"Pediatr Dev Pathol"},{"issue":"6","key":"2041_CR12","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1172\/JCI114939","volume":"86","author":"MS Buchmann","year":"1990","unstructured":"Buchmann MS, Kvittingen EA, Nazer H, Gunasekaran T, Clayton PT, Sjovall J, et al. Lack of 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase\/isomerase in fibroblasts from a child with urinary excretion of 3 beta-hydroxy-delta 5-bile acids. A new inborn error of metabolism. J Clin Invest. 1990;86(6):2034\u20137.","journal-title":"J Clin Invest"},{"issue":"5","key":"2041_CR13","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0022-2275(20)42035-8","volume":"32","author":"H Ichimiya","year":"1991","unstructured":"Ichimiya H, Egestad B, Nazer H, Baginski ES, Clayton PT, Sjovall J. Bile acids and bile alcohols in a child with hepatic 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency: effects of chenodeoxycholic acid treatment. J Lipid Res. 1991;32(5):829\u201341.","journal-title":"J Lipid Res"},{"issue":"6","key":"2041_CR14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1046\/j.1442-200x.2000.01292.x","volume":"42","author":"M Kobayashi","year":"2000","unstructured":"Kobayashi M, Koike M, Sakiyama M, Okuda S, Okuda M, Tanaka T, et al. 3beta-hydroxy-delta5-C27-steroid dehydrogenase\/isomerase deficiency in a 23-year-old woman. Pediatr Int. 2000;42(6):685\u20138.","journal-title":"Pediatr Int"},{"issue":"4","key":"2041_CR15","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1210\/jc.2002-021580","volume":"88","author":"JB Cheng","year":"2003","unstructured":"Cheng JB, Jacquemin E, Gerhardt M, Nazer H, Cresteil D, Heubi JE, et al. Molecular genetics of 3beta-hydroxy-Delta5-C27-steroid oxidoreductase deficiency in 16 patients with loss of bile acid synthesis and liver disease. J Clin Endocrinol Metab. 2003;88(4):1833\u201341.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2041_CR16","doi-asserted-by":"publisher","first-page":"1310-20 e1","DOI":"10.1053\/j.gastro.2009.07.043","volume":"137","author":"E Gonzales","year":"2009","unstructured":"Gonzales E, Gerhardt MF, Fabre M, Setchell KD, Davit-Spraul A, Vincent I, et al. Oral cholic acid for hereditary defects of primary bile acid synthesis: a safe and effective long-term therapy. Gastroenterology. 2009;137(4):1310-20 e1\u20133.","journal-title":"Gastroenterology"},{"issue":"8","key":"2041_CR17","first-page":"625","volume":"51","author":"TJ Yang","year":"2013","unstructured":"Yang TJ, Xie XB, Yao WL, Wang HJ, Yu H, Wang XH. [Clinical features of a Chinese infant with inborn error of bile acid metabolism-3beta-hydroxy-Delta(5)-C27-steroid dehydrogenase deficiency and review of the literature]. Zhonghua Er Ke Za Zhi. 2013;51(8):625\u20139.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"5","key":"2041_CR18","first-page":"360","volume":"53","author":"X Li","year":"2015","unstructured":"Li X, Huang Z, Wang H. [Infant with 3beta-hydroxy-Delta(5)-C27 steroid dehydrogenase deficiency: report of two cases and literatures review]. Zhonghua Er Ke Za Zhi. 2015;53(5):360\u20135.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"1","key":"2041_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4103\/0366-6999.172603","volume":"129","author":"HY Huang","year":"2016","unstructured":"Huang HY, Zhou H, Wang H, Chen YX, Fang F. Novel mutations in the 3beta-hydroxy-5-C27-steroid dehydrogenase gene (HSD3B7) in a patient with neonatal cholestasis. Chin Med J (Engl). 2016;129(1):98\u2013100.","journal-title":"Chin Med J (Engl)"},{"issue":"6","key":"2041_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/MPG.0000000000001734","volume":"65","author":"AA Al-Hussaini","year":"2017","unstructured":"Al-Hussaini AA, Setchell KDR, AlSaleem B, Heubi JE, Lone K, Davit-Spraul A, et al. Bile acid synthesis disorders in Arabs: a 10-year screening study. J Pediatr Gastroenterol Nutr. 2017;65(6):613\u201320.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2041_CR21","first-page":"1025a-6a","volume":"70","author":"T Mizuochi","year":"2019","unstructured":"Mizuochi T, Takei H, Nittono H, Kimura A. Bile acid synthesis disorders in Japan: a long-term outcome and an efficacy of chenodeoxycholic acid treatment. Hepatology. 2019;70:1025a\u20136a.","journal-title":"Hepatology"},{"issue":"3","key":"2041_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ajhg.2017.07.014","volume":"101","author":"LM Starita","year":"2017","unstructured":"Starita LM, Ahituv N, Dunham MJ, Kitzman JO, Roth FP, Seelig G, et al. Variant interpretation: functional assays to the rescue. Am J Hum Genet. 2017;101(3):315\u201325.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"2041_CR23","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/jlb\/lsx038","volume":"4","author":"L Hoffman-Andrews","year":"2017","unstructured":"Hoffman-Andrews L. The known unknown: the challenges of genetic variants of uncertain significance in clinical practice. J Law Biosci. 2017;4(3):648\u201357.","journal-title":"J Law Biosci"},{"issue":"1","key":"2041_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41390-019-0548-8","volume":"87","author":"NL Wang","year":"2020","unstructured":"Wang NL, Lu Y, Gong JY, Xie XB, Lin J, Abuduxikuer K, et al. Molecular findings in children with inherited intrahepatic cholestasis. Pediatr Res. 2020;87(1):112\u20137.","journal-title":"Pediatr Res"},{"issue":"10","key":"2041_CR25","doi-asserted-by":"publisher","first-page":"e0164058","DOI":"10.1371\/journal.pone.0164058","volume":"11","author":"NL Wang","year":"2016","unstructured":"Wang NL, Lu YL, Zhang P, Zhang MH, Gong JY, Lu Y, et al. A specially designed multi-gene panel facilitates genetic diagnosis in children with intrahepatic cholestasis: simultaneous test of known large insertions\/deletions. PLoS One. 2016;11(10):e0164058.","journal-title":"PLoS One"},{"issue":"5","key":"2041_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"key":"2041_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mam.2017.03.003","volume":"56","author":"FM Vaz","year":"2017","unstructured":"Vaz FM, Ferdinandusse S. Bile acid analysis in human disorders of bile acid biosynthesis. Mol Aspects Med. 2017;56:10\u201324.","journal-title":"Mol Aspects Med"},{"issue":"7","key":"2041_CR28","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1373\/clinchem.2015.238238","volume":"61","author":"W Zhang","year":"2015","unstructured":"Zhang W, Jha P, Wolfe B, Gioiello A, Pellicciari R, Wang J, et al. Tandem mass spectrometric determination of atypical 3beta-hydroxy-Delta5-bile acids in patients with 3beta-hydroxy-Delta5-C27-steroid oxidoreductase deficiency: application to diagnosis and monitoring of bile acid therapeutic response. Clin Chem. 2015;61(7):955\u201363.","journal-title":"Clin Chem"},{"issue":"3","key":"2041_CR29","first-page":"190","volume":"17","author":"F Rinawi","year":"2015","unstructured":"Rinawi F, Iancu TC, Hartman C, Cohen H, Yarden-Bilavsky H, Bar Lev MR, et al. Fat malabsorption due to bile acid synthesis defect. Isr Med Assoc J. 2015;17(3):190\u20132.","journal-title":"Isr Med Assoc J"},{"issue":"3","key":"2041_CR30","doi-asserted-by":"publisher","first-page":"7266","DOI":"10.4081\/pr.2017.7266","volume":"9","author":"G Bossi","year":"2017","unstructured":"Bossi G, Giordano G, Rispoli GA, Maggiore G, Naturale M, Marchetti D, et al. Atypical clinical presentation and successful treatment with oral cholic acid of a child with defective bile acid synthesis due to a novel mutation in the HSD3B7 gene. Pediatr Rep. 2017;9(3):7266.","journal-title":"Pediatr Rep"},{"issue":"6","key":"2041_CR31","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1002\/hep.26599","volume":"58","author":"P Fickert","year":"2013","unstructured":"Fickert P, Krones E, Pollheimer MJ, Thueringer A, Moustafa T, Silbert D, et al. Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice. Hepatology. 2013;58(6):2056\u201369.","journal-title":"Hepatology"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02041-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-02041-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02041-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T19:46:15Z","timestamp":1633895175000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-02041-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2041"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-02041-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,9]]},"assertion":[{"value":"3 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committees on Human Research of the Children\u2019s Hospital of Fudan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KDRS and JEH have minor equity in Asklepion Pharmaceuticals and are consultants to Retrophin. JSW consulted for Ethyptharm. The other authors disclose no conflicts.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"417"}}